BofA raised the firm’s price target on CME Group (CME) to $209 from $201 and keeps an Underperform rating on the shares. Looking ahead to 2026, the firm now favors the alternative asset managers to online brokers due to what it sees as a better valuation and positioning setup combined with a stronger macro backdrop, the analyst tells investors in a note on the brokers, asset managers and exchanges group.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CME:
- Crypto Currents: Twenty One Capital debuts on NYSE
- Unusually active option classes on open December 8th
- As Copper Soars, U.S. Miners and EV Stocks Come Into Focus
- The Week That Was, The Week Ahead: Macro & Markets, Dec. 7
- Cautious Neutral Stance on CME Group Amid Mixed Signals and Macroeconomic Uncertainty